Talk:Siponimod
Appearance
This is the talk page for discussing improvements to the Siponimod article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Siponimod.
|
History
[edit]Original BAF312 page was wp:PROD'd 8:32 8 Jun 2009 [1] then 32 minutes later being changed to a redirect to Multiple sclerosis research which probably had pre-existing text. The original PROD seems unjustified since it was already in phase II clinical trials. - Rod57 (talk) 07:37, 6 January 2016 (UTC)
ToDO
[edit]Start to fill in drugbox, Find and add phase II trial results - Rod57 (talk) 07:40, 6 January 2016 (UTC)
Wiki Education assignment: PHMD 2040 Service - Learning Spring 2023
[edit]This article was the subject of a Wiki Education Foundation-supported course assignment, between 2 January 2023 and 30 June 2023. Further details are available on the course page. Student editor(s): Ely.yatun (article contribs).
— Assignment last updated by JustinxLane (talk) 19:03, 2 June 2023 (UTC)
Categories:
- Start-Class chemicals articles
- Low-importance chemicals articles
- Start-Class Molecular Biology articles
- Unknown-importance Molecular Biology articles
- All WikiProject Molecular Biology pages
- Start-Class pharmacology articles
- Mid-importance pharmacology articles
- WikiProject Pharmacology articles
- Start-Class medicine articles
- Mid-importance medicine articles
- All WikiProject Medicine pages